Israeli Company's Vaccine Blocks 90% of Cancer Types
Vaxil BioTherapeutics's ImMucin trains immune system to fight cancer cells and prevent the disease's return for early stages and remission.
Vaxil BioTherapeutics's ImMucin trains immune system to fight cancer cells and prevent the disease's return for early stages and remission.
